1 / 38

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention (and Coronary Revascularization)

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention (and Coronary Revascularization). PCI Revascularization Recommendations Pre-Procedural Considerations Procedural Considerations Post-Procedural Considerations.

vallerie
Download Presentation

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention (and Coronary Revascularization)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention (and Coronary Revascularization)

  2. PCI Revascularization Recommendations Pre-Procedural Considerations Procedural Considerations Post-Procedural Considerations

  3. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionRevascularization Recommendations

  4. UPLM PCI to Improve Survival in SIHD Recommendations • 3 complementary recommendations based on the risk of PCI complication, likelihood of long-term durability, and surgical risk • Includes a new PCI class IIa recommendation • SYNERGY score and STS score can be used to help guide UPLM revascularization decisions

  5. UPLM PCI to Improve Survival (ACS)

  6. Single and Multivessel CAD PCI To Improve Survival(SIHD)

  7. PCI to Improve Symptoms

  8. Cumulative 3-Year Incidence of MACE in Patients With 3-Vessel CAD in the SYNTAX trial Results For Each SYNTAX Tercile

  9. Hybrid Coronary Revascularization

  10. Clinical Factors That May Influence The Choice of Revascularization Diabetes mellitus Chronic kidney disease Completeness of revascularization LV systolic dysfunction Previous CABG Ability to comply with and tolerate DAPT

  11. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionPCI Revascularization Recommendations

  12. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionPre-Procedural Considerations

  13. Pre-Procedural Considerations

  14. Contrast-Induced Acute Kidney Injury (AKI) Risk Reduction

  15. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionProcedural Considerations

  16. Vascular Access

  17. General Considerations in Deciding Between an Early Invasive Strategy and an Initial Conservative Strategy in UA/NSTEMI

  18. Coronary Angiography in STEMI

  19. PCI in STEMI

  20. Cardiogenic Shock

  21. Recommendations for Initial Reperfusion Therapy When Cardiogenic Shock Complicates STEMI Dashed lines indicate that the procedure should be performed in patients with specific indications only

  22. Coronary StentsRisk of restenosis needs to be weighted against the likelihood of the patient to be able to tolerate and comply with (prolonged) DAPT

  23. Clinical Situations Associated With DES or BMS Selection Preference

  24. Aspirin in PCI

  25. P2Y12 Inhibitors and DAPT

  26. Antiplatelet And Antithrombin Rx at the Time of PCI

  27. GP IIb/IIIa Inhibitor Therapy

  28. Dosing of Parental Anticoagulants During PCI

  29. Heparin-Induced Thrombocytopenia (HIT)

  30. No Reflow Pharmacological Therapy

  31. SVG PCI

  32. PCI in Specific Anatomic Situations

  33. Periprocedural MI Assessment

  34. Vascular Closure Devices (VCD)

  35. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionPost-Procedural Considerations

  36. P2Y12 Inhibitor Rx Post-Stent (P2Y12 Inhibitor = clopidogrel, prasugrel or ticagrelor)

  37. PPI Therapy and DAPTRecommendations based on risk of GI bleeding

  38. Restenosis

More Related